Citius Oncology, Inc. (CTOR)

NCM – Real Time Price. Currency in USD

0.78

+0.05 (6.86%)

Market open: Aug 12, 2026, 2:02 PM EDT

0.73

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

Gross Profit

Operating expenses (excl. COGS)

-24M

-21M

-1M

-138K

Operating Income

-24M

-21M

-1M

-138K

Non-operating income, total

-182K

519K

Pretax income

-24M

-21M

381K

Equity in earnings

Taxes

-1M

-576K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-25M

-21M

381K

Discontinued operations

Net income

-25M

-21M

381K

Dilution adjustment

Preferred dividends

Citius Oncology, Inc. (CTOR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Citius Oncology, Inc. (CTOR)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Citius Oncology, Inc. (CTOR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Citius Oncology, Inc. (CTOR)

Income Statement (Annual)

Income Statement (Annual)